We have to start looking at how tough the Bard1 technology is to commercialise. Results from early R&D is always an indicator of an application but trying to clinically translate research into a commercially viable test for patients is not an easy thing to do. Perhaps the Bar1 tech although good as a research application is not the horse that the company wants to back (low hanging fruit and quickest to market). How many years have BD1 been working on the Bard1 test now...Just saying...
- Forums
- ASX - By Stock
- IIQ
- Ann: Commencement of Legal Proceedings Against BARD1
Ann: Commencement of Legal Proceedings Against BARD1, page-56
-
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
|
|||||
Last
56.0¢ |
Change
-0.025(4.27%) |
Mkt cap ! $61.75M |
Open | High | Low | Value | Volume |
58.0¢ | 60.0¢ | 56.0¢ | $46.60K | 81.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 11847 | 56.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.0¢ | 9849 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 11847 | 0.560 |
5 | 24611 | 0.555 |
4 | 38550 | 0.550 |
1 | 10000 | 0.545 |
3 | 11000 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.590 | 9849 | 1 |
0.600 | 5002 | 1 |
0.610 | 15000 | 1 |
0.620 | 11837 | 1 |
0.625 | 4689 | 1 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online